IDEAYA Biosciences Announces the Promotion of Dr. Michael White to President, Research and Development
Why now
Thesis: Personnel news, no clinical or financial update
Catalyst to watch: Clinical trial data or partnership news
Main risk: No efficacy or revenue information given
Why it matters
Internal R&D promotion at a small oncology biotech signals pipeline continuity but no data readout.
Details
SOUTH SAN FRANCISCO, Calif., Sept. 28, 2026 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, today announced the promotion of Dr. Michael White, from Chief Scientific Officer...
Sources
- prnewswire · 2026-09-28 10:00 UTC